Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butyrate in Gulf War Illness
NCT05367245Phase 2Recruiting
- Sponsor
- VA Office of Research & Development
- Start
- Jan 2024
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of calcium butyrate + magnesium butyrate in Gulf War illness (GWI) (2 arms), sponsored by VA Office of Research & Development. Primary endpoint: Veterans Short Form 36-Item Health Survey Physical Component Summary at 20 weeks. Started Jan 2024; status: recruiting.
02
Drugs
calcium butyrate + magnesium butyrate
03
Conditions
Gulf War illness (GWI)
Beyond the preview
Go deeper on NCT05367245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05367245.